Skip to main content
2024 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Certified Pharmacy Executive Leader
Digital Health & Informatics
Digital Health & Informatics
Diversity, Equity and Inclusion
Diversity, Equity and Inclusion
Health & Wellness
Health & Wellness
Opioids & Pain Management
Opioids & Pain Management
Sterile Compounding
Sterile Compounding
Back
Handout

Educational Sessions

Taming the Poison Paradise: Clindamycin or Linezolid for Necrotizing Soft Tissue Infections

Sunday, December 8, 2024
12:00 PM – 1:00 PM  
Location: MCCNO, Theater A, Level 2
CE Credits: 1.00 contact hours
Activity #: 0204-0000-24-231-L01-P
Activity Type: Application-based
Target Audience: Pharmacist

Learning Objectives:

  • Analyze the current place of clindamycin in therapy for Group A Streptococcus (GAS) suspected necrotizing soft tissue infections (NSTIs).
  • Compare the advantages and disadvantages of linezolid and clindamycin for GAS-suspected NSTIs.
  • Identify patient-specific factors to promote one antitoxin agent over another.